WJA
IBB icon

Williams Jones & Associates’s iShares Biotechnology ETF IBB Stock Holding History

Williams Jones & Associates’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$19.9M Sell
182,426
-10,137
-5% -$1.08M 0.41% 59
2019
Q1 		$21.5M Buy
192,563
+1,515
+0.8% +$166K 0.48% 55
2018
Q4 		$18.4M Sell
191,048
-89,162
-32% -$9.46M 0.5% 54
2018
Q3 		$34.2M Buy
280,210
+1,694
+0.6% +$199K 0.69% 49
2018
Q2 		$30.6M Sell
278,516
-29,785
-10% -$3.19M 0.67% 50
2018
Q1 		$32.9M Buy
308,301
+6,214
+2% +$689K 0.76% 47
2017
Q4 		$32.3M Buy
302,087
+6,851
+2% +$732K 0.73% 47
2017
Q3 		$32.8M Buy
295,236
+17,568
+6% +$1.88M 0.81% 41
2017
Q2 		$28.7M Buy
277,668
+132,288
+91% +$13M 0.72% 44
2017
Q1 		$14.2M Sell
145,380
-62,031
-30% -$5.94M 0.37% 69
2016
Q4 		$18.3M Sell
207,411
-60,105
-22% -$5.47M 0.52% 52
2016
Q3 		$25.8M Sell
267,516
-10,131
-4% -$964K 0.76% 40
2016
Q2 		$23.8M Buy
277,647
+73,287
+36% +$6.58M 0.73% 45
2016
Q1 		$17.8M Buy
204,360
+111,606
+120% +$9.98M 0.83% 39
2015
Q4 		$10.5M Sell
92,754
-5,241
-5% -$569K 0.48% 61
2015
Q3 		$9.91M Sell
97,995
-1,338
-1% -$160K 0.45% 61
2015
Q2 		$12.2M Sell
99,333
-675
-0.7% -$80.8K 0.47% 61
2015
Q1 		$11.4M Buy
100,008
+4,242
+4% +$468K 0.46% 64
2014
Q4 		$9.68M Buy
95,766
+2,652
+3% +$258K 0.4% 71
2014
Q3 		$8.49M Buy
93,114
+1,410
+2% +$124K 0.39% 68
2014
Q2 		$7.86M Sell
91,704
-110,934
-55% -$8.74M 0.35% 72
2014
Q1 		$16M Buy
202,638
+98,766
+95% +$8.23M 0.32% 78
2013
Q4 		$7.86M Buy
103,872
+2,652
+3% +$188K 0.38% 71
2013
Q3 		$7.07M Sell
101,220
-450
-0.4% -$29.5K 0.36% 71
2013
Q2 		$5.89M Buy
+101,670
New +$5.88M 0.29% 84

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Williams Jones & Associates's IBB Position: Q2 2019 in Review

Williams Jones & Associates reduced its iShares Biotechnology ETF (IBB) stake by 5.3% in Q2 2019, selling an estimated $1.08M and leaving 182,426 shares worth $19.9M. The position accounts for 0.41% of the portfolio, ranked #59.

Williams Jones & Associates first reported a position in IBB in Q2 2013 and has held it in 25 quarters since. The position peaked at $34.2M in Q3 2018. 646 funds tracked by Wall St. Rank hold IBB as of Q2 2019.

  • Williams Jones & Associates held 182,426 shares of iShares Biotechnology ETF worth $19.9M as of Q2 2019.
  • Williams Jones & Associates sold 10,137 iShares Biotechnology ETF shares in Q2 2019, an estimated $1.08M.
  • iShares Biotechnology ETF made up 0.41% of Williams Jones & Associates's portfolio in Q2 2019, its #59 holding.
  • Williams Jones & Associates first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 25 quarters since.
  • Williams Jones & Associates's iShares Biotechnology ETF position peaked at $34.2M in Q3 2018.
  • 646 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2019.

Based on Williams Jones & Associates's 13F filing for Q2 2019, filed 14 Aug 2019.